Biostage, Inc.

BSTG · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$1,700-$1,823-$1,659-$2,228
Dep. & Amort.$25$26$25$144
Deferred Tax$0$0$0$0
Stock-Based Comp.$495$537$485$83
Change in WC$0$0$0-$603
Other Non-Cash-$285$319$391$6,032
Operating Cash Flow-$1,465-$941-$758$3,428
Investing Activities
PP&E Inv.$0$0$0$11
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$3,766
Investing Cash Flow$0$0$0$3,777
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2,000$0$0$490
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0-$80
Other Fin. Act.$2,000$0$0-$4,992
Financing Cash Flow$2,000$0$0-$5,072
Forex Effect-$2-$1$0-$6,195
Net Chg. in Cash$533-$942-$758$3,458
Supplemental Information
Beg. Cash$786$1,728$2,486-$972
End Cash$1,319$786$1,728$2,486
Free Cash Flow-$1,465-$941-$758$3,439
Biostage, Inc. (BSTG) Financial Statements & Key Stats | AlphaPilot